Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Purpose: To evaluate the diagnostic performance of dynamic contrast-enhanced (DCE)-MRI in predicting malignancy after percutaneous biopsy diagnosis of atypical ductal hyperplasia (ADH).Methods and Materials: In this retrospective study, 68 lesions (66 women) with percutaneous biopsy diagnosis of ADH...
| Publicado en: | European Radiology Vol. 30; no. 7; pp. 4069 - 4082 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | diagnostic images research tables/charts Journal Article |
| Publicado: |
Springer Nature
Jul2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143855621&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 143855621 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09387994 NPH jtl: European Radiology issn: 09387994 maglogo: N pubinfo: dt: Jul2020 vid: 30 iid: 7 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 143855621 143855621 144042323 NLM32144463 143855621 10.1007/s00330-020-06701-3 NLM32144463 143855621 ppf: 4069 ppct: 13 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision. aug: au: Bertani, Valeria Urbani, Martina La Grassa, Manuela Balestreri, Luca Berger, Nicole Frauenfelder, Thomas Boss, Andreas Marcon, Magda affil: Department of Oncologic Radiation Therapy and Diagnostic Imaging, Centro di Riferimento Oncologico, Via Franco Gallini, 2, 33081, Aviano, Italy sug: subj: Unnecessary Procedures Breast Neoplasms Pathology Adenocarcinoma Pathology Magnetic Resonance Imaging Contrast Media Administration and Dosage Breast Breast Pathology Ultrasonography Breast Neoplasms Surgery Sensitivity and Specificity Mammography Biopsy, Needle Adenocarcinoma Surgery Retrospective Design Female Middle Age Adult Biopsy Aged Human Middle Aged: 45-64 years Adult: 19-44 years Aged: 65+ years Female ab: Purpose: To evaluate the diagnostic performance of dynamic contrast-enhanced (DCE)-MRI in predicting malignancy after percutaneous biopsy diagnosis of atypical ductal hyperplasia (ADH).Methods and Materials: In this retrospective study, 68 lesions (66 women) with percutaneous biopsy diagnosis of ADH and pre-operative breast DCE-MRI performed between January 2016 and December 2017 were included. Two radiologists reviewed in consensus mammography, ultrasound, and MR images. The final diagnosis after surgical excision was used as standard of reference. Clinical and imaging features were compared in patients with and without upgrade to malignancy after surgery. The diagnostic performance of DCE-MRI in predicting malignant upgrade was evaluated.Results: A 9-gauge vacuum-assisted biopsy was performed in 40 (58.8%) cases and a 14-gauge core needle biopsy in 28 (41.2%) cases. Upgrade to malignancy was observed in 17/68 (25%) lesions, including 4/17 (23.5%) cases of invasive cancer and 13/17 (76.5%) cases of ductal carcinoma in situ (DCIS). In 16/17 (94.1%) malignant and 20/51 (39.2%) benign lesions, a suspicious enhancement could be recognized in DCE-MRI. The malignant lesion without suspicious enhancement was a low-grade DCIS (4 mm size). Sensitivity, specificity, positive predictive value, and negative predictive value of DCE-MRI on predicting malignancy were respectively 94.1%, 60.7%, 44.4%, and 96.8%. No other clinical or imaging features were significantly different in patients with and without upgrade to malignancy.Conclusion: After a percutaneous biopsy diagnosis of ADH, malignancy can be ruled out in most of the cases, if no suspicious enhancement is present in the biopsy area at DCE-MRI. Breast DCE-MRI may be used to avoid surgery in more than half of the patients with final benign diagnosis.Key Points: • Breast DCE-MRI can safely rule out malignancy if no suspicious enhancement is present in the biopsy area after a percutaneous biopsy diagnosis of ADH. • All cases of upgrade to high-grade DCIS and invasive cancers can be identified at breast DCE-MRI after a percutaneous biopsy diagnosis of ADH. • Breast DCE-MRI may be used to avoid surgery in more than half of the patients with final benign diagnosis. pubtype: Academic Journal doctype: diagnostic images research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|